Greater adherence to lifestyle recommendations after cancer diagnosis is associated with lower mortality in the UK Biobank

dc.contributor.authorByrne, S.
dc.contributor.authorHypponen, E.
dc.contributor.authorBenyamin, B.
dc.contributor.authorBoyle, T.
dc.date.issued2025
dc.description.abstractBackground: Research supporting the current recommendation to adhere to a healthy lifestyle following cancer diagnosis is limited. We investigated whether a healthy lifestyle after diagnosis is associated with a lower risk of mortality among those diagnosed with any malignant cancer and breast, colorectal, and prostate cancers. Methods: In 2006 to 2010, UK Biobank participants (ages 37– 73 years) were assessed. Analyses were restricted to those with a malignant cancer diagnosis prior to baseline (n ¼ 20,805, including 5,845 breast, 1,943 colorectal, and 2,715 prostate cancer cases). Participants were followed for all-cause and cancer- specific death up to November 2022. A lifestyle index was determined based on lifestyle recommendations for cancer prevention. Cox regression was used to examine associations with all-cause and cancer-specific mortality among those with any cancer, and separately for breast, colorectal, and prostate cancers, adjusting for relevant confounders. 1,2,3 , and Terry Boyle 1,2,3 Results: There were 4,328 deaths and 3,354 cancer-specific deaths in the 258,985 person-years of follow-up. A higher lifestyle index, representing greater adherence to recommendations, was associated with a lower risk of all-cause mortality [any cancer - highest vs. lowest lifestyle index tertile: HR (95% confidence interval) ¼ 0.77 (0.71, 0.83); breast: 0.75 (0.64, 0.88); colorectal: 0.68 (0.52, 0.89); and prostate: 0.73 (0.59, 0.89)] and cancer-specific mortality in all populations examined [any cancer: 0.82 (0.75, 0.89); breast: 0.88 (0.71, 1.09); colorectal: 0.58 (0.36, 0.94); prostate: 0.70 (0.53, 0.93)], although evidence was weaker for cancer-specific mortality among colorectal and breast cancer survivors. Conclusions: Our findings provide evidence to support the recommendation to follow a healthy lifestyle after cancer diagnosis to prolong life. Impact: Clinical guidelines and public health programs promoting a healthy lifestyle to cancer survivors may prolong life.
dc.description.statementofresponsibilityStephanie Byrne, Elina Hyppönen, Beben Benyamin, Terry Boyle
dc.identifier.citationCancer Epidemiology, Biomarkers and Prevention, 2025; 34(5):669-675
dc.identifier.doi10.1158/1055-9965.EPI-24-1783
dc.identifier.issn1055-9965
dc.identifier.issn1538-7755
dc.identifier.orcidByrne, S. [0000-0001-5566-3467]
dc.identifier.urihttps://hdl.handle.net/2440/146307
dc.language.isoen
dc.publisherAmerican Association for Cancer Research
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/GNT2025349
dc.rights©2025 American Association for Cancer Research
dc.source.urihttps://doi.org/10.1158/1055-9965.epi-24-1783
dc.subjecthealthy lifestyle; cancer diagnosis; mortality
dc.subject.meshNeoplasms
dc.subject.meshProstatic Neoplasms
dc.subject.meshPatient Compliance
dc.subject.meshLife Style
dc.subject.meshUK Biobank
dc.titleGreater adherence to lifestyle recommendations after cancer diagnosis is associated with lower mortality in the UK Biobank
dc.typeJournal article
pubs.publication-statusPublished online

Files

Collections